Skip to content
healthcare.dev

buprenorphine and naloxone

NDC 0054-0188, buprenorphine and naloxone, tablet, from Hikma Pharmaceuticals USA Inc..

Product NDC
0054-0188
Status
Listed
Labeler
Hikma Pharmaceuticals USA Inc.
Dosage form
TABLET
Route
SUBLINGUAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA203326
DEA schedule
CIII
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0054-0188 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BUPRENORPHINE HYDROCHLORIDE2 mg/1
  • NALOXONE HYDROCHLORIDE DIHYDRATE.5 mg/1

Pharmacologic classes

Opioid Antagonist [EPC]; Opioid Antagonists [MoA]; Partial Opioid Agonist [EPC]; Partial Opioid Agonists [MoA]

Package NDCNDC-11Package
0054-0188-130005401881330 TABLET in 1 BOTTLE (0054-0188-13)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/713db2c6-0544-4633-b874-cfbeaf93db89
  • NADAC price for package 00054018813

    GET /v1/drugs/nadac/00054018813

Use it

Look up 0054-0188 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0054-0188 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0054-0188. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.